ATOS - ATOSSA THERAPEUTICS, INC.
4.92
0.200 4.065%
Share volume: 136,363
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$4.72
0.20
0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-13-2024 | 08-12-2024 | 11-12-2024 | 03-25-2025 | 05-13-2025 | 08-12-2025 | 11-12-2025 | |
| Assets | ||||||||
| Total Assets | 91.087 M | 85.858 M | 79.477 M | 76.444 M | 70.747 M | 64.515 M | 58.012 M | |
| Current Assets | 87.055 M | 81.718 M | 77.111 M | 74.457 M | 68.744 M | 62.517 M | 55.678 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 83.960 M | 79.526 M | 74.766 M | 71.084 M | 65.116 M | 57.857 M | 51.845 M | |
| Total Non-current Assets | 1.710 M | 1.710 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 4.032 M | 4.140 M | 2.366 M | 1.987 M | 2.003 M | 1.998 M | 2.334 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 91.087 M | 85.858 M | 79.477 M | 76.444 M | 70.747 M | 64.515 M | 58.012 M | |
| Total liabilities | 5.328 M | 5.696 M | 5.796 M | 4.967 M | 5.425 M | 6.820 M | 8.225 M | |
| Total current liabilities | 5.328 M | 5.696 M | 5.796 M | 4.967 M | 5.425 M | 6.820 M | 8.225 M | |
| Accounts Payable | 1.230 M | 1.056 M | 1.561 M | 679.000 K | 1.165 M | 2.010 M | 3.536 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 85.759 M | 80.162 M | 73.681 M | 71.477 M | 65.322 M | 57.695 M | 49.787 M | |
| Common stock | 279.400 M | 279.852 M | 280.601 M | 284.744 M | 285.307 M | 286.103 M | 286.887 M | |
| Retained earnings | -192.166 M | -198.215 M | -205.445 M | -211.792 M | -218.510 M | -226.933 M | -235.625 M |